Tuesday, Apr 16, 2019 8:00a -
Thursday, Apr 18, 2019 5:00p
Hyatt Regency Boston
1 Avenue de Lafayette
Boston, MA 02111
Lectures & Conferences
Collaborate with your peers at the Neuroimmunology Drug Development Summit (NIDD), the first industry-focused networking forum to learn and share insight on how to successfully target chronic neuroinflammation as a universal therapeutic for various neurological diseases.
With an emphasis on neurodegeneration, NIDD will provide a discussion-led platform for you to discover the best strategies and most innovative technologies to aid your future neuroimmunological research.
Join the 70+ world class experts from AbbVie, Sanofi, Denali, Alector and Eisai to successfully guide the development of clinically efficacious therapeutics.
Conference + 2 Workshops: USD 4097.0,
Early Bird Price: USD 3897.0,
Conference + 1 Workshop: USD 3498.0,
Early Bird Price: USD 3298.0
Speakers: Sally Ishizaka (Eisai), Richard Ransohoff (Third Rock Ventures), Thomas Misko (AbbVie), Tarek Samad (Sanofi), Robert Nelson (MindImmune Therapeutics), Ajay Verma (United Neuroscience)